BELATACEPT
UNII E3B2GI648A

Substance Identification & Data

This profile provides standardized clinical and technical data for Belatacept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E3B2GI648A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 706808-37-9 and the RxNorm Concept ID (RxCUI) 1112973. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

E3B2GI648A

CAS Registry Number

706808-37-9

RxNorm Concept ID

1112973

Detailed Substance Profile

Preferred Name

BELATACEPT

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

E3B2GI648A

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C80255

National Cancer Institute reference terminology for clinical and research data.

INN ID

8627

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

QQ-105

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Belatacept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BELATACEPT

Common Names & Synonyms

BELATACEPT [EMA EPAR]

BELATACEPT [INN]

BELATACEPT [MART.]

BELATACEPT [MI]

BELATACEPT [PURPLE BOOK CDER]

BELATACEPT [USAN]

BELATACEPT [VANDF]

BELATACEPT [WHO-DD]

CTLA-4 (ANTIGEN) (29-TYROSINE,104-GLUTAMIC ACID) (HUMAN EXTRACELLULAR DOMAIN-CONTAINING FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN MONOCLONAL FC DOMAIN-CONTAINING FRAGMENT), BIMOL. (120->120')-DISULFIDE